Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.234 SEK | +5.88% | -13.33% | -97.66% |
May. 22 | Xbrane Successfully Scale Up Xdivane- Biosimilar Candidate to Opdivo®? | CI |
May. 16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 |